Gencove
Dedicated to making genomic data more accessible and interpretable through molecular and software tools.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Oct 2021.)
New York City New York (HQ)
Financials
Estimates*
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 1.1m | 2.7m | 3.1m |
| % growth | - | 157 % | 15 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$1.0m | Seed | ||
$3.0m | Series A | ||
$330k | Grant | ||
| N/A | $11.8m | Series A | |
$10.0m | Series A | ||
| Total Funding | €23.8m | ||
Recent News about Gencove
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.